GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyundai Bioscience Co Ltd (XKRX:048410) » Definitions » Price-to-Free-Cash-Flow

Hyundai Bioscience Co (XKRX:048410) Price-to-Free-Cash-Flow : N/A (As of Jun. 08, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Hyundai Bioscience Co Price-to-Free-Cash-Flow?

As of today (2024-06-08), Hyundai Bioscience Co's share price is ₩19570.00. Hyundai Bioscience Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-293.32. Hence, Hyundai Bioscience Co's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Hyundai Bioscience Co's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, Hyundai Bioscience Co's highest Price-to-Free-Cash-Flow Ratio was 262.55. The lowest was 152.73. And the median was 184.91.

XKRX:048410's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 30.545
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Hyundai Bioscience Co's Free Cash Flow per Share for the three months ended in Mar. 2024 was ₩-198.16. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₩-293.32.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 30.40% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -25.00% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was -9.40% per year.

During the past 13 years, Hyundai Bioscience Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 68.80% per year. The lowest was -60.70% per year. And the median was -0.20% per year.


Hyundai Bioscience Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Hyundai Bioscience Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyundai Bioscience Co Price-to-Free-Cash-Flow Chart

Hyundai Bioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hyundai Bioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hyundai Bioscience Co's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Hyundai Bioscience Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hyundai Bioscience Co's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hyundai Bioscience Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hyundai Bioscience Co's Price-to-Free-Cash-Flow falls into.



Hyundai Bioscience Co Price-to-Free-Cash-Flow Calculation

Hyundai Bioscience Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=19570.00/-293.322
=N/A

Hyundai Bioscience Co's Share Price of today is ₩19570.00.
Hyundai Bioscience Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-293.32.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Hyundai Bioscience Co  (XKRX:048410) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Hyundai Bioscience Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Hyundai Bioscience Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyundai Bioscience Co (XKRX:048410) Business Description

Traded in Other Exchanges
N/A
Address
150 North-Ahyun Road, 3rd Floor Academic Cooperation Building, Ehwa Women’s University, Seodaemun-gu, Seoul, KOR
Hyundai Bioscience Co Ltd is a Korean biotechnology company. The company is engaged in developing and commercializing bio-fusion technology with the purpose of delivering active ingredients safely and efficiently to the body. It has developed Vitabrid CG, a biomaterial that binds vitamin C with bio-friendly mineral layers, which is a beneficial ingredient in skin brightening, anti-aging, and anti-inflammation; and Vitabrid C12, a premium skincare brand.

Hyundai Bioscience Co (XKRX:048410) Headlines

No Headlines